Compare TBPH & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBPH | GOOS |
|---|---|---|
| Founded | 2013 | 1957 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 908.9M | 931.6M |
| IPO Year | 2013 | 2016 |
| Metric | TBPH | GOOS |
|---|---|---|
| Price | $16.87 | $8.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $18.40 | $12.60 |
| AVG Volume (30 Days) | 576.4K | ★ 641.5K |
| Earning Date | 05-04-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | $12.21 |
| Revenue Next Year | N/A | $5.16 |
| P/E Ratio | ★ N/A | $75.22 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.99 | $8.75 |
| 52 Week High | $21.03 | $14.69 |
| Indicator | TBPH | GOOS |
|---|---|---|
| Relative Strength Index (RSI) | 50.80 | 36.42 |
| Support Level | $16.80 | $8.75 |
| Resistance Level | $17.17 | $10.42 |
| Average True Range (ATR) | 0.06 | 0.33 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 33.33 | 10.63 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale; Direct to Consumer (DTC), and Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia-Pacific, and Europe, the Middle East, and Africa.